Spearbio
Business Development Manager, Immunoassays & Biomarkers (San Francisco)
Remote. Posted 7 months ago
The role
The Business Development Manager will introduce ultra-sensitive Immunoassays to the Life Sciences and CRO markets. This role involves managing the sales funnel and promoting kit sales and Assay Service solutions.
What you will do
- Act as expert on complex client sales presentations
- Provide sales planning and strategic thinking on customer engagement
- Demonstrate understanding of Neuroscience market dynamics
- Provide direct coverage as primary point person and manage the entire funnel
- Promote kit sales by providing instrument and Assay Service solutions
- Lead the Business Development team in customer logistics and follow up
- Assist the VP of Business Development in training and support
- Achieve consistent track record exceeding quotas and revenue targets
- Drive commercial messaging with the marketing team and support Lead Generation
- Work with Assay Services leader to support funnel building and provide Voice of Customer feedback
Required qualifications
- MS or PhD in Biology, Biochemistry, Bioengineering or related field
- 6-10+ years of an established track record in sales or business development
- Experience presenting ultrasensitive immunoassays or neurology IVD products to customers
- Strong network and knowledge of San Francisco biotech/pharma landscape
- Clear and pro-active communicator
- Advanced commercial sales acumen
- Ability to ask the right questions of potential customers
- Ability to clearly present technology solutions
- Ability to translate observations and customer feedback into strategy
- Comfortable providing and receiving feedback
- Ability to collaborate within a team environment
- Willingness to travel up to 30-40%
Benefits
- Competitive compensation
- Meaningful stock ownership
- Comprehensive benefits
About the company
Spear Bio, founded in 2021, is a well-funded and rapidly growing biotech start-up headquartered in Woburn, Massachusetts. The company uses proprietary SPEAR technology to provide scalable, ultrasensitive solutions for measuring low-abundant biomarkers.